1. Home
  2. ALTS vs ACOG Comparison

ALTS vs ACOG Comparison

Compare ALTS & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTS
  • ACOG
  • Stock Information
  • Founded
  • ALTS 1976
  • ACOG 2000
  • Country
  • ALTS United States
  • ACOG Canada
  • Employees
  • ALTS N/A
  • ACOG N/A
  • Industry
  • ALTS
  • ACOG
  • Sector
  • ALTS
  • ACOG
  • Exchange
  • ALTS NYSE
  • ACOG Nasdaq
  • Market Cap
  • ALTS 159.4M
  • ACOG 80.3M
  • IPO Year
  • ALTS N/A
  • ACOG N/A
  • Fundamental
  • Price
  • ALTS $7.88
  • ACOG $10.80
  • Analyst Decision
  • ALTS
  • ACOG Strong Buy
  • Analyst Count
  • ALTS 0
  • ACOG 1
  • Target Price
  • ALTS N/A
  • ACOG $20.00
  • AVG Volume (30 Days)
  • ALTS 298.1K
  • ACOG 67.2K
  • Earning Date
  • ALTS 08-18-2025
  • ACOG 08-14-2025
  • Dividend Yield
  • ALTS N/A
  • ACOG N/A
  • EPS Growth
  • ALTS N/A
  • ACOG N/A
  • EPS
  • ALTS N/A
  • ACOG N/A
  • Revenue
  • ALTS $18,046,000.00
  • ACOG $2,928,654.00
  • Revenue This Year
  • ALTS $185.91
  • ACOG N/A
  • Revenue Next Year
  • ALTS $64.93
  • ACOG N/A
  • P/E Ratio
  • ALTS N/A
  • ACOG N/A
  • Revenue Growth
  • ALTS N/A
  • ACOG N/A
  • 52 Week Low
  • ALTS $1.29
  • ACOG $3.75
  • 52 Week High
  • ALTS $10.95
  • ACOG $11.54
  • Technical
  • Relative Strength Index (RSI)
  • ALTS 47.13
  • ACOG N/A
  • Support Level
  • ALTS $7.06
  • ACOG N/A
  • Resistance Level
  • ALTS $8.38
  • ACOG N/A
  • Average True Range (ATR)
  • ALTS 0.91
  • ACOG 0.00
  • MACD
  • ALTS -0.17
  • ACOG 0.00
  • Stochastic Oscillator
  • ALTS 33.51
  • ACOG 0.00

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: